Tag: Sanofi

Sonofi and Sobi get Altuviiio FDA approval to treat hemophilia A

Raghuram Kadari- February 27, 2023

Sonofi and Sobi have secured the approval of the US Food and Drug Administration (FDA) for their Altuviiio for hemophilia A treatment. Altuviiio, previously known ... Read More

Sanofi, Regeneron get Dupixent EC approval for eosinophilic esophagitis

Raghuram Kadari- February 1, 2023

French pharmaceutical company Sanofi and Regeneron, an American biotechnology company, have received the approval of the European Commission (EC) to market their Dupixent (dupilumab) injection ... Read More

Regeneron gets Libtayo approval in Japan for advanced cervical cancer

Raghuram Kadari- December 31, 2022

Regeneron Pharmaceuticals has secured the approval of the Japanese Ministry of Health, Labor and Welfare (MHLW) to manufacture and market the company’s Libtayo (cemiplimab) for ... Read More

Innovent Biologics, Sanofi to expedite development of cancer drugs in China

pallavi123- August 6, 2022

Chinese biopharma company Innovent Biologics and French pharma giant Sanofi have entered into a partnership that aims to bring innovative drugs to patients in China ... Read More

Adagene, Sanofi signs collaboration and license deal worth up to $2.5bn

pallavi123- March 6, 2022

Adagene, a US-based biopharma company, has signed a collaboration and license deal worth up to $2.5 billion plus royalties with Sanofi to produce masked monoclonal ... Read More

ABL Bio, Sanofi sign $1bn deal for Parkinson’s candidate ABL301

pallavi123- January 14, 2022

ABL Bio has bagged a global collaboration and licensing deal worth up to $1.06 billion with Sanofi to develop and commercialize its drug candidate ABL301 ... Read More

Sanofi to acquire UK-based biopharma company Kymab in $1.4bn worth deal

pharmanewsdaily- January 12, 2021

Sanofi acquisition of Kymab : French pharma giant Sanofi has signed a deal worth up to $1.45 billion to acquire Kymab, a UK-based clinical-stage biopharma ... Read More

Sanofi to acquire US biopharma company Principia Biopharma for $3.7bn

pharmanewsdaily- August 17, 2020

Sanofi acquisition of Principia Biopharma : French pharma giant Sanofi has signed an all-cash deal worth $3.68 billion to acquire Principia Biopharma, a late-stage California-based ... Read More

Perrigo acquires skincare and hair loss treatment brands from Sanofi

pallavi123- August 11, 2020

Ireland-based Perrigo Company has agreed to acquire three over-the-counter (OTC) skincare and hair loss treatment brands sold across Eastern Europe, namely Emolium, Iwostin, and Loxon, ... Read More

Sanofi, GSK to supply 60 million doses of COVID-19 vaccine to UK

pharmanewsdaily- July 30, 2020

Pharma majors Sanofi and GlaxoSmithKline (GSK) have reached an agreement with the UK government for supplying up to 60 million doses of their jointly developed ... Read More